CANbridge Pharmaceuticals Inc. announced the appointment of Dr. Hu Lan as an Independent, Non-executive Director and a member of the remuneration committee of the Board with effect from February 16, 2022. Currently, she is the Chairman of the Board and General Manager of Beijing Amcare Medical Management Co. Ltd.; the Chairman of the Board of Beijing Meizhong Airui Tumor Hospital Co.

Ltd.; the independent Director of Beijing Yida Shidai Technology Development Co. Ltd. and the Executive Director and General Manager of Beijing Xuanhe Yazhi Management Consulting Co. Ltd.Dr. Hu is a member of 12th and 13th Beijing Municipal Committee of the Chinese People's Political Consultative Conference, a position she has held since 2013.

From 2002-2004, she was an Investment Manager at JP Morgan Chase Bank. Dr. Hu has over 18 years of experience in healthcare investment, operations and administrative management. The company also announced that Mr. James Arthur Geraghty has ceased to be the member of the Remuneration Committee; Dr. Richard James Gregory has ceased to be a member of the audit committee of the Board; and Mr. Geraghty was appointed as a member of the Audit Committee.